On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

CannAssist International Corp. (CNSC) Engages Communications Industry Leader IBN to Share Story, Reach Millions

  • CNSC partners with InvestorBrandNetwork to maximize communication, refine messaging and outreach.
  • CannAssist focused on marketing Xceptol consumer brand, which provides products featuring proprietary CiBiDinol technology.
  • IBN brings 15-plus years of experience assisting more than 500 client partners improve communications within investment community.

Recognizing the critical nature of communications to the success of a business, CannAssist International (OTCQB: CNSC) has selected to partner with InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities (https://cnw.fm/s0eOs). CannAssist, a biotechnological pharmaceutical and wellness company, owns Xceptor Labs, an R&D and raw material manufacturer, which also has its own product line.

“We are pleased to engage IBN to maximize our communication with existing and potential shareholders while refining our overall messaging and outreach,” said CannAssist CEO Mark Palumbo.

Currently, CannAssist is focused on marketing its Xceptol consumer brand, which provides products that feature Xceptor Labs’ proprietary CiBiDinol technology. According to CannAssist, CiBiDinol is a method of creating CBD products that have better absorption than other oil-based products currently available. CiBiDinol provides CBD in a format that is more in line with the body’s natural bioactivity, the company said. Specifically, CiBiDinol is designed to tackle issues with oil-soluble CBD molecules, such as delivery, bioavailability and short shelf-life. CannAssist notes that the product in the brand also offers more predictable potency.

The CannAssist story is certainly one worth telling, and IBN is focused on telling that story through a variety of ways. IBN has built an investor-based distribution network of 5,000-plus key syndication outlets; the company also produces various newsletters and manages a variety of social media platforms, wire service, blogs and other outreach tools. The purpose of the IBN partnership is to generate greater awareness for CannAssist International Corp.

“The cannabidiol market has been on fire since the 2018 Farm Bill was signed into law,” said IBN director of client solutions Chris Johnson. “In 2018, the global CBD market was valued at $4.6 billion, and it’s forecast to reach $23.6 billion by 2025, according to Grand View Research. CannAssist is uniquely positioned to capitalize on this market growth.

“Based on current revenue from raw material sales, retail sales and the Xceptol brand’s international distribution, CannAssist expects to reach first-year sales of $5 million,” Johnson continued. “We’re excited to customize our comprehensive suite of corporate communications solutions for the company as it seeks to expand its product pipeline and achieve steady sales growth in the years ahead.”

Johnson noted that with 15-plus years of experience assisting more than 500 client partners improve communications within the investment community, IBN is the ideal organization to work alongside CannAssist. Through its family of 50-plus trusted brands and millions of social media followers, IBN is uniquely positioned to offer CannAssist the essential expertise, insight and tools to reach a wider audience of investors, consumers and more.

CannAssist, owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company. Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol (“CBD”) products under the Xceptol brand.

For more information, visit the company’s website at www.CannAssistInternational.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://cnw.fm/CNSC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Archives

Select A Month

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo USA CBD Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722